Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Peripheral Neuropathic Pain Drug industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
GW Pharmaceuticals
Abbott
ProPhase Labs
MedImmune
Bristol-Myers
MSD
Pfizer
Lilly
Crealta Pharmaceuticals
Novartis
GSK
Roche
ONO PHARMACEUTICAL
Depomed
Endo
Bayer
By Type:
Type 1
Type 2
Type 3
By Application:
Application 1
Application 2
Application 3
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Peripheral Neuropathic Pain Drug Market Overview 2018-2029
-
1.1 China Peripheral Neuropathic Pain Drug Industry Development Overview
-
1.2 China Peripheral Neuropathic Pain Drug Industry Development History
-
1.3 China Peripheral Neuropathic Pain Drug Industry Market Size (2018-2029)
-
1.4 China Peripheral Neuropathic Pain Drug Market Analysis by Type from Production Side
-
1.4.1 China Peripheral Neuropathic Pain Drug Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)
-
1.4.2 China Peripheral Neuropathic Pain Drug Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)
-
1.4.3 China Peripheral Neuropathic Pain Drug Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)
-
1.5 China Peripheral Neuropathic Pain Drug Market Analysis by Application from Consumption End
-
1.5.1 China Peripheral Neuropathic Pain Drug Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)
-
1.5.2 China Peripheral Neuropathic Pain Drug Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)
-
1.5.3 China Peripheral Neuropathic Pain Drug Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)
-
1.6 China Peripheral Neuropathic Pain Drug Market Analysis by Region
-
1.6.1 North China Peripheral Neuropathic Pain Drug Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Peripheral Neuropathic Pain Drug Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Peripheral Neuropathic Pain Drug Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Peripheral Neuropathic Pain Drug Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Peripheral Neuropathic Pain Drug Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Peripheral Neuropathic Pain Drug Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Peripheral Neuropathic Pain Drug Market Size and Growth Rate from 2018-2029
Chapter 2 China Peripheral Neuropathic Pain Drug Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Peripheral Neuropathic Pain Drug Market Status and Competition at home and abroad in 2023
-
2.2.2 China Peripheral Neuropathic Pain Drug Market Status and Competition Analysis in 2023
-
2.2.3 China Peripheral Neuropathic Pain Drug Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Peripheral Neuropathic Pain Drug Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Peripheral Neuropathic Pain Drug Industry Development
Chapter 3 Peripheral Neuropathic Pain DrugIndustry Chain Analysis
-
3.1 Peripheral Neuropathic Pain Drug Industry Chain
-
3.2 Peripheral Neuropathic Pain Drug Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Peripheral Neuropathic Pain Drug Market
-
3.3 Peripheral Neuropathic Pain Drug Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Peripheral Neuropathic Pain Drug Market
Chapter 4 China Peripheral Neuropathic Pain Drug Market, by Type
-
4.1 China Peripheral Neuropathic Pain Drug Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Peripheral Neuropathic Pain Drug Total Production Volume and Growth Rate from Production Side
-
4.5 China Peripheral Neuropathic Pain Drug Production Volume and Growth Rate, by Type
-
4.5.1 China Peripheral Neuropathic Pain Drug Production Volume and Growth Rate of Type 1
-
4.5.2 China Peripheral Neuropathic Pain Drug Production Volume and Growth Rate of Type 2
-
4.5.3 China Peripheral Neuropathic Pain Drug Production Volume and Growth Rate of Type 3
Chapter 5 China Peripheral Neuropathic Pain Drug Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Peripheral Neuropathic Pain Drug Total Market Size and Growth Rate from Consumption End
-
5.5 China Peripheral Neuropathic Pain Drug Market Size and Growth Rate, by Application
-
5.5.1 China Peripheral Neuropathic Pain Drug Market Size and Growth Rate of Application 1
-
5.5.2 China Peripheral Neuropathic Pain Drug Market Size and Growth Rate of Application 2
-
5.5.3 China Peripheral Neuropathic Pain Drug Market Size and Growth Rate of Application 3
Chapter 6 China Peripheral Neuropathic Pain Drug Market, by Region
-
6.1 China Peripheral Neuropathic Pain Drug Production Volume and Production Value, by Region
-
6.2 China Peripheral Neuropathic Pain Drug Sales Volume and Sales Value, by Region
Chapter 7 North China Peripheral Neuropathic Pain Drug Market Analysis
-
7.1 North China Peripheral Neuropathic Pain Drug Market, by Type
-
7.2 North China Peripheral Neuropathic Pain Drug Market, by Application
Chapter 8 Central China Peripheral Neuropathic Pain Drug Market Analysis
-
8.1 Central China Peripheral Neuropathic Pain Drug Market, by Type
-
8.2 Central China Peripheral Neuropathic Pain Drug Market, by Application
Chapter 9 South China Peripheral Neuropathic Pain Drug Market Analysis
-
9.1 South China Peripheral Neuropathic Pain Drug Market, by Type
-
9.2 South China Peripheral Neuropathic Pain Drug Market, by Application
Chapter 10 East China Peripheral Neuropathic Pain Drug Market Analysis
-
10.1 East China Peripheral Neuropathic Pain Drug Market, by Type
-
10.2 East China Peripheral Neuropathic Pain Drug Market, by Application
Chapter 11 Northeast China Peripheral Neuropathic Pain Drug Market Analysis
-
11.1 Northeast China Peripheral Neuropathic Pain Drug Market, by Type
-
11.2 Northeast China Peripheral Neuropathic Pain Drug Market, by Application
Chapter 12 Southwest China Peripheral Neuropathic Pain Drug Market Analysis
-
12.1 Southwest China Peripheral Neuropathic Pain Drug Market, by Type
-
12.2 Southwest China Peripheral Neuropathic Pain Drug Market, by Application
Chapter 13 Northwest China Peripheral Neuropathic Pain Drug Market Analysis
-
13.1 Northwest China Peripheral Neuropathic Pain Drug Market, by Type
-
13.2 Northwest China Peripheral Neuropathic Pain Drug Market, by Application
Chapter 14 Company Profiles
-
14.1 GW Pharmaceuticals
-
14.1.1 GW Pharmaceuticals Company Profile
-
14.1.2 GW Pharmaceuticals Peripheral Neuropathic Pain Drug Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Abbott
-
14.2.1 Abbott Company Profile
-
14.2.2 Abbott Peripheral Neuropathic Pain Drug Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 ProPhase Labs
-
14.3.1 ProPhase Labs Company Profile
-
14.3.2 ProPhase Labs Peripheral Neuropathic Pain Drug Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 MedImmune
-
14.4.1 MedImmune Company Profile
-
14.4.2 MedImmune Peripheral Neuropathic Pain Drug Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Bristol-Myers
-
14.5.1 Bristol-Myers Company Profile
-
14.5.2 Bristol-Myers Peripheral Neuropathic Pain Drug Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 MSD
-
14.6.1 MSD Company Profile
-
14.6.2 MSD Peripheral Neuropathic Pain Drug Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Pfizer
-
14.7.1 Pfizer Company Profile
-
14.7.2 Pfizer Peripheral Neuropathic Pain Drug Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Lilly
-
14.8.1 Lilly Company Profile
-
14.8.2 Lilly Peripheral Neuropathic Pain Drug Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Crealta Pharmaceuticals
-
14.9.1 Crealta Pharmaceuticals Company Profile
-
14.9.2 Crealta Pharmaceuticals Peripheral Neuropathic Pain Drug Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Novartis
-
14.10.1 Novartis Company Profile
-
14.10.2 Novartis Peripheral Neuropathic Pain Drug Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 GSK
-
14.11.1 GSK Company Profile
-
14.11.2 GSK Peripheral Neuropathic Pain Drug Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 Roche
-
14.12.1 Roche Company Profile
-
14.12.2 Roche Peripheral Neuropathic Pain Drug Market Performance
-
14.12.3 Product&Service Introduction
-
14.13 ONO PHARMACEUTICAL
-
14.13.1 ONO PHARMACEUTICAL Company Profile
-
14.13.2 ONO PHARMACEUTICAL Peripheral Neuropathic Pain Drug Market Performance
-
14.13.3 Product&Service Introduction
-
14.14 Depomed
-
14.14.1 Depomed Company Profile
-
14.14.2 Depomed Peripheral Neuropathic Pain Drug Market Performance
-
14.14.3 Product&Service Introduction
-
14.15 Endo
-
14.15.1 Endo Company Profile
-
14.15.2 Endo Peripheral Neuropathic Pain Drug Market Performance
-
14.15.3 Product&Service Introduction
-
14.16 Bayer
-
14.16.1 Bayer Company Profile
-
14.16.2 Bayer Peripheral Neuropathic Pain Drug Market Performance
-
14.16.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Peripheral Neuropathic Pain Drug Industry Research Conclusions
-
15.2 Peripheral Neuropathic Pain Drug Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Peripheral Neuropathic Pain Drug Industry Market Size (2018-2029)
-
Figure China Peripheral Neuropathic Pain Drug Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)
-
Figure China Peripheral Neuropathic Pain Drug Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)
-
Figure China Peripheral Neuropathic Pain Drug Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)
-
Figure China Peripheral Neuropathic Pain Drug Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)
-
Figure China Peripheral Neuropathic Pain Drug Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)
-
Figure China Peripheral Neuropathic Pain Drug Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)
-
Figure North China Peripheral Neuropathic Pain Drug Market Size and Growth Rate from 2018-2029
-
Figure Central China Peripheral Neuropathic Pain Drug Market Size and Growth Rate from 2018-2029
-
Figure South China Peripheral Neuropathic Pain Drug Market Size and Growth Rate from 2018-2029
-
Figure East China Peripheral Neuropathic Pain Drug Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Peripheral Neuropathic Pain Drug Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Peripheral Neuropathic Pain Drug Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Peripheral Neuropathic Pain Drug Market Size and Growth Rate from 2018-2029
-
Figure Peripheral Neuropathic Pain Drug Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Peripheral Neuropathic Pain Drug Market Share by Type in 2018
-
Figure China Peripheral Neuropathic Pain Drug Market Share by Type in 2023
-
Figure China Peripheral Neuropathic Pain Drug Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Peripheral Neuropathic Pain Drug Production Volume and Growth Rate of Type 1 (2018-2023)
-
Figure China Peripheral Neuropathic Pain Drug Production Volume and Growth Rate of Type 2 (2018-2023)
-
Figure China Peripheral Neuropathic Pain Drug Production Volume and Growth Rate of Type 3 (2018-2023)
-
Figure China Peripheral Neuropathic Pain Drug Market Share by Application in 2018
-
Figure China Peripheral Neuropathic Pain Drug Market Share by Application in 2023
-
Figure China Peripheral Neuropathic Pain Drug Total Market Size and Growth Rate from Consumption End
-
Figure China Peripheral Neuropathic Pain Drug Market Size and Growth Rate of Application 1 (2018-2023)
-
Figure China Peripheral Neuropathic Pain Drug Market Size and Growth Rate of Application 2 (2018-2023)
-
Figure China Peripheral Neuropathic Pain Drug Market Size and Growth Rate of Application 3 (2018-2023)
-
Table China Peripheral Neuropathic Pain Drug Production Volume by Region (2018-2023)
-
Table China Peripheral Neuropathic Pain Drug Production Volume Share by Region (2018-2023)
-
Figure China Peripheral Neuropathic Pain Drug Production Volume Share by Region (2018-2023)
-
Table China Peripheral Neuropathic Pain Drug Production Value by Region (2018-2023)
-
Table China Peripheral Neuropathic Pain Drug Production Value Share by Region (2018-2023)
-
Figure China Peripheral Neuropathic Pain Drug Production Value Share by Region (2018-2023)
-
Table China Peripheral Neuropathic Pain Drug Sales Volume by Region (2018-2023)
-
Table China Peripheral Neuropathic Pain Drug Sales Volume Share by Region (2018-2023)
-
Figure China Peripheral Neuropathic Pain Drug Sales Volume Share by Region (2018-2023)
-
Table China Peripheral Neuropathic Pain Drug Sales Value by Region (2018-2023)
-
Table China Peripheral Neuropathic Pain Drug Sales Value Share by Region (2018-2023)
-
Figure China Peripheral Neuropathic Pain Drug Sales Value Share by Region (2018-2023)
-
Table North China Peripheral Neuropathic Pain Drug Production Volume by Type (2018-2023)
-
Table North China Peripheral Neuropathic Pain Drug Production Volume Share by Type (2018-2023)
-
Figure North China Peripheral Neuropathic Pain Drug Production Volume Share by Type (2018-2023)
-
Table North China Peripheral Neuropathic Pain Drug Sales Volume by Application (2018-2023)
-
Table North China Peripheral Neuropathic Pain Drug Sales Volume Share by Application (2018-2023)
-
Figure North China Peripheral Neuropathic Pain Drug Sales Volume Share by Application (2018-2023)
-
Table Central China Peripheral Neuropathic Pain Drug Production Volume by Type (2018-2023)
-
Table Central China Peripheral Neuropathic Pain Drug Production Volume Share by Type (2018-2023)
-
Figure Central China Peripheral Neuropathic Pain Drug Production Volume Share by Type (2018-2023)
-
Table Central China Peripheral Neuropathic Pain Drug Sales Volume by Application (2018-2023)
-
Table Central China Peripheral Neuropathic Pain Drug Sales Volume Share by Application (2018-2023)
-
Figure Central China Peripheral Neuropathic Pain Drug Sales Volume Share by Application (2018-2023)
-
Table South China Peripheral Neuropathic Pain Drug Production Volume by Type (2018-2023)
-
Table South China Peripheral Neuropathic Pain Drug Production Volume Share by Type (2018-2023)
-
Figure South China Peripheral Neuropathic Pain Drug Production Volume Share by Type (2018-2023)
-
Table South China Peripheral Neuropathic Pain Drug Sales Volume by Application (2018-2023)
-
Table South China Peripheral Neuropathic Pain Drug Sales Volume Share by Application (2018-2023)
-
Figure South China Peripheral Neuropathic Pain Drug Sales Volume Share by Application (2018-2023)
-
Table East China Peripheral Neuropathic Pain Drug Production Volume by Type (2018-2023)
-
Table East China Peripheral Neuropathic Pain Drug Production Volume Share by Type (2018-2023)
-
Figure East China Peripheral Neuropathic Pain Drug Production Volume Share by Type (2018-2023)
-
Table East China Peripheral Neuropathic Pain Drug Sales Volume by Application (2018-2023)
-
Table East China Peripheral Neuropathic Pain Drug Sales Volume Share by Application (2018-2023)
-
Figure East China Peripheral Neuropathic Pain Drug Sales Volume Share by Application (2018-2023)
-
Table Northeast China Peripheral Neuropathic Pain Drug Production Volume by Type (2018-2023)
-
Table Northeast China Peripheral Neuropathic Pain Drug Production Volume Share by Type (2018-2023)
-
Figure Northeast China Peripheral Neuropathic Pain Drug Production Volume Share by Type (2018-2023)
-
Table Northeast China Peripheral Neuropathic Pain Drug Sales Volume by Application (2018-2023)
-
Table Northeast China Peripheral Neuropathic Pain Drug Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Peripheral Neuropathic Pain Drug Sales Volume Share by Application (2018-2023)
-
Table Southwest China Peripheral Neuropathic Pain Drug Production Volume by Type (2018-2023)
-
Table Southwest China Peripheral Neuropathic Pain Drug Production Volume Share by Type (2018-2023)
-
Figure Southwest China Peripheral Neuropathic Pain Drug Production Volume Share by Type (2018-2023)
-
Table Southwest China Peripheral Neuropathic Pain Drug Sales Volume by Application (2018-2023)
-
Table Southwest China Peripheral Neuropathic Pain Drug Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Peripheral Neuropathic Pain Drug Sales Volume Share by Application (2018-2023)
-
Table Northwest China Peripheral Neuropathic Pain Drug Production Volume by Type (2018-2023)
-
Table Northwest China Peripheral Neuropathic Pain Drug Production Volume Share by Type (2018-2023)
-
Figure Northwest China Peripheral Neuropathic Pain Drug Production Volume Share by Type (2018-2023)
-
Table Northwest China Peripheral Neuropathic Pain Drug Sales Volume by Application (2018-2023)
-
Table Northwest China Peripheral Neuropathic Pain Drug Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Peripheral Neuropathic Pain Drug Sales Volume Share by Application (2018-2023)
-
Table GW Pharmaceuticals Company Profile
-
Table GW Pharmaceuticals Peripheral Neuropathic Pain Drug Revenue, Price and Gross (2018-2023)
-
Table Abbott Company Profile
-
Table Abbott Peripheral Neuropathic Pain Drug Revenue, Price and Gross (2018-2023)
-
Table ProPhase Labs Company Profile
-
Table ProPhase Labs Peripheral Neuropathic Pain Drug Revenue, Price and Gross (2018-2023)
-
Table MedImmune Company Profile
-
Table MedImmune Peripheral Neuropathic Pain Drug Revenue, Price and Gross (2018-2023)
-
Table Bristol-Myers Company Profile
-
Table Bristol-Myers Peripheral Neuropathic Pain Drug Revenue, Price and Gross (2018-2023)
-
Table MSD Company Profile
-
Table MSD Peripheral Neuropathic Pain Drug Revenue, Price and Gross (2018-2023)
-
Table Pfizer Company Profile
-
Table Pfizer Peripheral Neuropathic Pain Drug Revenue, Price and Gross (2018-2023)
-
Table Lilly Company Profile
-
Table Lilly Peripheral Neuropathic Pain Drug Revenue, Price and Gross (2018-2023)
-
Table Crealta Pharmaceuticals Company Profile
-
Table Crealta Pharmaceuticals Peripheral Neuropathic Pain Drug Revenue, Price and Gross (2018-2023)
-
Table Novartis Company Profile
-
Table Novartis Peripheral Neuropathic Pain Drug Revenue, Price and Gross (2018-2023)
-
Table GSK Company Profile
-
Table GSK Peripheral Neuropathic Pain Drug Revenue, Price and Gross (2018-2023)
-
Table Roche Company Profile
-
Table Roche Peripheral Neuropathic Pain Drug Revenue, Price and Gross (2018-2023)
-
Table ONO PHARMACEUTICAL Company Profile
-
Table ONO PHARMACEUTICAL Peripheral Neuropathic Pain Drug Revenue, Price and Gross (2018-2023)
-
Table Depomed Company Profile
-
Table Depomed Peripheral Neuropathic Pain Drug Revenue, Price and Gross (2018-2023)
-
Table Endo Company Profile
-
Table Endo Peripheral Neuropathic Pain Drug Revenue, Price and Gross (2018-2023)
-
Table Bayer Company Profile
-
Table Bayer Peripheral Neuropathic Pain Drug Revenue, Price and Gross (2018-2023)
-
